Scientists identify biomarker for progression and drug response in brain cancer
Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which ...
Oct 16, 2017
0
1